Maine Center for Cancer Medicine

Testicular Cancer News

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute. What’s more—cancer incidence... Continue Reading

Marijuana May Increase Risk of Testicular Cancer (September 21, 2012)

Recreational marijuana use may increase the risk of developing subtypes of testicular cancer that have a worse prognosis, according to the results of a study published early online in the journal Cancer. Testicular cancer is the most common cancer diagnosed... Continue Reading

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according to the results of a study published in The Lancet... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading

Do Complementary Therapies Work? – Ask the expert about herbs, acupuncture, and other complementary therapies (November 4, 2011)

Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service; Laurance S. Rockefeller Chair Integrative Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), click here for Dr. Cassileth’s bio Dr. Cassileth is a world-renowned... Continue Reading

Clinical Trial Participation Is Inadequate (August 31, 2011)

A large proportion of cancer patients do not enroll in clinical trials, and those who do participate may not adequately represent age groups, cancer stages, cancer types, and racial and ethnic groups. These findings were recently reported in the Annals... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s important to update this information periodically... Continue Reading

Survivors of Childhood Cancer Face Risk of More Cancer (July 11, 2011)

Children who survive cancer have an increased risk of developing cancer later in life. These findings were recently reported in the Journal of Clinical Oncology. The good news about childhood cancer is that increasingly more children are surviving. These... Continue Reading

New Substances Added to List of Cancer-Causing Agents (June 21, 2011)

In the most recent version of the National Toxicology Program’s Report on Carcinogens, two new substances have been classified as “known human carcinogens” and six others have been classified as “reasonably anticipated to be human carcinogens.” The... Continue Reading

Latest Testicular Cancer News By Stage


Recurrent Testicular Cancer

Marijuana May Increase Risk of Testicular Cancer (September 21, 2012)

Recreational marijuana use may increase the risk of developing subtypes of testicular cancer that have a worse prognosis, according to the results of a study published early online in the journal Cancer. Testicular cancer is the most common cancer diagnosed... Continue Reading

Paclitaxel/Gemzar Provides Long-Term Survival in Refractory Testicular Cancer (June 14, 2011)

Treatment with the chemotherapy agents paclitaxel and Gemzar® (gemcitabine) provides long-term survival and possible cure among some patients with testicular cancer that has stopped responding to prior therapies. These results were recently presented... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading

More Recurrent Testicular Cancer

Stage I-II Testicular Cancer

Marijuana May Increase Risk of Testicular Cancer (September 21, 2012)

Recreational marijuana use may increase the risk of developing subtypes of testicular cancer that have a worse prognosis, according to the results of a study published early online in the journal Cancer. Testicular cancer is the most common cancer diagnosed... Continue Reading

Low-Dose CT Scans Effective for Surveillance of Early Testicular Cancer (June 15, 2011)

Low-dose computed tomography (CT) scans provide a reliable method for surveillance and reduce radiation exposure by 40-60% among patients with Stage I testicular cancer. These results were recently presented at the 2011 annual meeting of the American... Continue Reading

New Genes Linked to Testicular Cancer (June 28, 2010)

Scientists have discovered three new genes associated with testicular cancer, according to the results of a study published in Nature Genetics.[1] Testicular cancer is the most common type of cancer in men ages 15 to 45. The incidence of testicular cancer... Continue Reading

Men with Infertility May Have Increased Risk of Testicular Cancer (March 8, 2009)

Men with Infertility May Have Increased Risk of Testicular Cancer Men with infertility are three times more likely to develop testicular cancer compared with fertile men, according to the results of a study published in the Archives of Internal Medicine.[1] The... Continue Reading

Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer (March 8, 2009)

Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer Among men with Stage I seminoma (a type of testicular cancer), post-surgery treatment with a single dose of the chemotherapy drug carboplatin is as effective as two to... Continue Reading

More Stage I-II Testicular Cancer

Stage III Testicular Cancer

Marijuana May Increase Risk of Testicular Cancer (September 21, 2012)

Recreational marijuana use may increase the risk of developing subtypes of testicular cancer that have a worse prognosis, according to the results of a study published early online in the journal Cancer. Testicular cancer is the most common cancer diagnosed... Continue Reading

New Genes Linked to Testicular Cancer (June 28, 2010)

Scientists have discovered three new genes associated with testicular cancer, according to the results of a study published in Nature Genetics.[1] Testicular cancer is the most common type of cancer in men ages 15 to 45. The incidence of testicular cancer... Continue Reading

More Stage III Testicular Cancer